ESC Premium Access

Change in CHA2DS2-VASc score (delta CHA2DS2-VASc score) and the risk of thromboembolism over 12-years follow-up in initially low-risk patients with first-diagnosed atrial fibrillation

Congress Presentation

About the speaker

Associate Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)
34 presentations
3 followers

10 more presentations in this session

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

Speaker: Doctor X. Li (Princeton, NJ, US)

Thumbnail

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Speaker: Assistant Professor H. Yu (Seoul, KR)

Thumbnail

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Thumbnail

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Speaker: Mr S. van der Wall (Leiden, NL)

Thumbnail

The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)

Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention

Speakers: Associate Professor T. Potpara, Doctor X. Li, Assistant Professor H. Yu, Doctor M. Esteve Pastor, Mr S. van der Wall...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk